Genetic association of low-density lipoprotein receptor-related protein 2 (LRP2) with plasma lipid levels

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 6, 2007, Pages 310-316

  Mii, Akiko ^a   Nakajima, Toshiaki ^a   Fujita, Yuko ^a   Iino, Yasuhiko ^a   Kamimura, Kouhei ^b   Bujo, Hideaki ^c   Saito, Yasushi ^c   Emi, Mitsuru ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Awa Medical Association Hospital   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Association study; Haplotype; Linkage disequilibrium (LD); Single nucleotide polymorphism (SNP)

Indexed keywords

CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEGALIN;

ARTICLE; BLOOD; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; JAPAN; SINGLE NUCLEOTIDE POLYMORPHISM;

CHOLESTEROL; CHOLESTEROL, LDL; GENOTYPE; HAPLOTYPES; HUMANS; HYPERCHOLESTEROLEMIA; JAPAN; LDL-RECEPTOR RELATED PROTEIN 2; LINKAGE DISEQUILIBRIUM; LIPIDS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 41049116180     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E494     Document Type: Article

References (26)

1. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, and Neaton JD: Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term and ABll-Cause Mortality and to Longevity. JAMA, 2000; 284:311-318
2. Hegele RA: Monogenic dislipidemias: window on determinants of plasma lipoprotein metabolism. Am J Hum Genet, 69:1161-1177
3. Cullen P, Funke H, Schulte H, and Assmann G: Lipoproteins and cardiovascular risk-from genetics to CHD prevention. J Atheroscler Thromb, 1997; 4:51-58
4. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, and Donnelly P: International HapMap Consortium. A haplotype map of the human genome. Nature, 2005; 437:1299-1320
5. Kerjaschki D and Farquhar MG: The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA, 1982; 79:5557-5561
6. Kerjaschki D and Farquhar MG: Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med, 1983; 157:667-686
7. Saito A, Pietromonaco S, Loo AK, and Farquhar MG: Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA, 1994; 91:9725-9729
8. Christensen EI and Birn H: Megalin and cubilin: multi-functional endocytic receptors. Nat Rev Mol Cell Biol, 2002; 3:256-266
9. Fujita Y, Ezura Y, Emi M, Ono S, Takada D, Takahashi K, Uemura K, Iino Y, Katayama Y, Bujo H, and Saito Y: Hypertriglyceridemia associated with amino acid variation N985Y of RP1 gene. J Hum Genet, 2003; 48:305-308
10. Fujita Y, Ezura Y, Bujyo H, Nakajima T, Takahashi K, Kamimura K, Iino Y, Katayama Y, Saito Y, and Emi M: Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia. J Hum Genet, 2005; 50:203-209
11. Ishii J, Nagano M, Kujiraoka T, Ishihara M, Egashira T, Takada D, Tsuji M, Hattori H, and Emi M: Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis. J Hum Genet, 2002; 47:366-369
12. Mein CA, Barratt BJ, Dunn MG, Siegmund T, Smith AN, Esposito L, Nutland S, Stevens HE, Wilson AJ, Philips MS, Jarvis N, Law S, de Arruda M, and Todd JA: Evaluation of single nucleotide polymorphism typing with invader on PCR amplidons and its automation. Genome Res, 2000; 10:330-343
13. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW. Sander TJ, de Arruda M, Arco DA, Neri BP, and Brow MA: Polymorphism, identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nature Biotechnol, 1999; 17:292-296
14. Livak KJ: Allelic discrimination using fluorogenic probes and the 5′ nucleotide assay. Genet Anal, 1999; 14:143-149
15. Fujiwara H, Emi M, Nagai H, Nishimura T, Konishi N, Kubota Y, Ichikawa T. Takahashi S, Shuin T, Habuchi T, Ogawa O, Inoue K, Sholnick MH, Swensen J, Camp NJ, and Tavtigian SV: Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series. J Hum Genet, 2002; 47:641-648
16. Millar PT, Sardina IB, Saccona NL, Putzel J, Laitinen T, Cao A, Kere J, Pilia G, Rice JP, and Kwok PY: Juxtaposed regions of extensive minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet, 2000; 25:324-328
17. Thompson EA, Deeb S, Walker D, and Motulsky AG: The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolioprotein genes. Am J Hum Genet, 1998; 42:113-124
18. Jinnai N, Sakagami T, Sekigawa T, Kakihara M, Nakajima T, Yoshida K, Goto S, Hasegawa T, Koshino T, Hasegawa Y, Inoue H, Suzuki N, Sano Y, and Inoue I: Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet, 2004; 13:3203-3217
19. Gliemann J: Receptors of the Low Density Lipoprotein (LDL) Receptor Family in Man. Multiple Functions of the Large Family Members via Interaction with Complex Ligands, Biol Chem, 1998; 379:951-964
20. Willnow TE, Nykjaer A, and Herz J: Lipoprotein receptors: new roles for ancient proteins. Nature Cell Biol, 1999; 1:E157-162
21. Schneider WJ and Nimpf J: LDL receptor relatives at the crossroad of endocytosis and signaling. Cell Mol Life Sci, 2003; 60:892-903
22. Hobbs HH, Brown MS, and Goldstein JL: Molecular genetics of the LDL receptor gene in familial hypercholesterolaemia. Hum Mutat, 1992; 1:445-466
23. Stefansson S, Chappell DA, Argraves KM, Strickland DK, and Argraves WS: Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein E100. J Biol Chem, 1995; 270:19417-19421
24. Hammad SM, Barth JK, Knaak C, and Argraves WS: Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins. J Biol Chem, 2000; 16:12003-12008
25. Oyama Y. Takeda T, Hama H, Tanuma A, Iino N, Sato K, Kaseda R, Ma M, Yamamoto T, Fujii H, Kazama JJ, Odani S, Terada Y, Mizuta K, Gejyo F, and Saito A: Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest, 2005; 85:522-531
26. Hama H, Saito A, Takeda T, Tanuma A, Xie Y, Sato K, Kazama JJ, and Gejyo F: Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by leptin receptor. Endocrinology, 2004; 145:3935-3940